Product Image

Huperzine-A 200 mcg

Nutricost
4.7
★ ★ ★ ★ ★
(567 ratings)
Huperzine 200 mcg
Product Image
Score82
Precise dosing and a focused formula are useful, but source and cycling details are missing. The potent serving is better suited to experienced, cautious users.
How scoring works
Quantity:240 Capsule(s) • (240 servings)
Goals:
Mental Focus
Brain Health
Cognitive Support
Productivity Boost

Score 82

Precise dosing and a focused formula are useful, but source and cycling details are missing. The potent serving is better suited to experienced, cautious users.
How scoring works
$19.95($0.08 per serving)
iHerb
$ 19.95
Report prices

Analysis

The 200 mcg Huperzine A serving may support short-term attention and memory through acetylcholine signaling. Its exact active amount is stated clearly, and the focused formula avoids unrelated ingredients.

One pathway cannot provide broad cognitive support, and evidence for routine productivity use in healthy adults remains limited. The upper-range amount also offers less room for a cautious first trial.

The label does not identify a botanical source or extract standardization. Cycling guidance is also absent even though Huperzine A can remain active long enough for cholinergic effects to accumulate with frequent dosing.

Who is it for
  • Experienced users seeking single-ingredient Huperzine A
  • People focused on short-term attention or memory support
Best for
  • Precisely stated active dosing
  • A long-supply single-ingredient format

Pros

  • Discloses the exact 200 mcg amount
  • Contains one focused active ingredient
  • Avoids a stimulant blend

Cons

  • Botanical source is not identified
  • No extract-standardization detail is provided
  • No cycling guidance accompanies the long-acting ingredient

Warnings

  • Huperzine A may cause nausea, dizziness, vivid dreams, muscle cramps, or a slowed heart rate.
  • Repeated use can allow cholinergic effects to build because the ingredient is long acting.
  • Acetylcholinesterase inhibitors and other cholinergic medicines may have stronger effects when combined with Huperzine A.

Nutrient quality

84 Highest impact

The precise huperzine A amount supports targeted cognitive use. Missing source detail and an upper-range amount without cycling guidance reduce quality and safety confidence.

.

Ingredient transparency

77 High impact

The active amount is disclosed without a hidden blend. Botanical source, cycling guidance, complete directions, and inactive ingredients are not supplied.

.

Customer satisfaction

70 High impact

The supplied average rating is strong. A substantial rating base makes the average reasonably dependable, but no detailed experience evidence was supplied.

.

Value for money

96 Highest impact

Serving economics are highly favorable. Formula quality supports the asking price well.

.
Report analysis

Goals

Mental Focus
Impact
Highest effect
B Goal FitA- Strength of SupportC CoverageA+ Formula Quality
Huperzine · 200 mcg

Huperzine A directly supports acetylcholine signaling and is well aligned with acute focus. The precisely stated 200 mcg amount is substantial for a single-ingredient capsule.

Human evidence for attention in healthy adults is less consistent than its mechanism suggests, and the source is not identified. Its long activity may increase nausea, dizziness, vivid dreams, or a slow heart rate, so repeated daily use warrants caution.

Study evidence
Huperzine Not classified

No linked studies yet.

Brain Health
Impact
High effect
B+ Goal FitB+ Strength of SupportD+ CoverageA Formula Quality
Huperzine · 200 mcg

Huperzine A directly slows acetylcholine breakdown and may support short-term memory and focus. The precise amount is potent, but the single pathway does not provide broad nutritional or structural brain support.

Source and extract-standardization details are absent despite the clear active amount. Repeated use may cause nausea, dizziness, vivid dreams, or a slow heart rate, and the long-acting ingredient is often cycled rather than taken continuously.

Study evidence
Huperzine Supportive 17 studies
Cognitive Support
Impact
High effect
B Goal FitA Strength of SupportD+ CoverageA- Formula Quality
Huperzine · 200 mcg

Huperzine A directly raises acetylcholine by slowing its breakdown, making it relevant to short-term memory and focus. The 200 mcg amount is potent and clearly disclosed, but evidence is stronger in cognitively impaired groups than in healthy users.

The narrow formula does not support circulation, stress resilience, or neuronal energy. Huperzine A is long acting and can cause nausea, slowed heart rate, muscle cramps, or other cholinergic effects, especially when combined with cholinergic medicines or used continuously.

Study evidence
Huperzine Supportive 22 studies
Productivity Boost
Impact
High effect
B Goal FitB+ Strength of SupportD CoverageA- Formula Quality
Huperzine · 200 mcg

Huperzine A directly prolongs acetylcholine signaling and may support memory and focus. Evidence is stronger in cognitive impairment than for routine productivity in healthy adults, and the long-acting mechanism increases side-effect concerns.

The precise 200 mcg amount sits at the upper end of common use, but botanical source and verification are absent. Repeated use may cause nausea, dizziness, vivid dreams, or a slow heart rate, so continuous daily use without cycling guidance is a notable limitation.

Study evidence
Huperzine No effect 1 study

Ingredients

IngredientAmount per serving
Huperzine-A
200 mcg
Gluten Free Adults 18–50
Report overview
Huperzine · 200 mcg OverallScore79
C Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value

The capsule provides a precise Huperzine A amount at the upper end of the commonly used range for focus support. The label does not identify the botanical source or extract standardization, which weakens confidence in ingredient verification. Lack of cycling guidance matters because Huperzine A can persist in the body and may cause cholinergic effects such as nausea, dizziness, or a slow heart rate with repeated use.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A phase II trial of huperzine A in mild to moderate Alzheimer disease.
    Rafii MS; Walsh S; Little JT; Behan K; Reynolds B; Ward C; Jin S; Thomas R; Aisen PS; Alzheimer's Disease Cooperative Study · Neurology · 2011
    Randomized trial210 participantsCognitive Support forHuperzine
  2. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.
    Wessinger CM; Inman CL; Weinstock J; Weiss EP · International journal of exercise science · 2025
    Randomized trial15 participantsBrain Health Productivity Boost forHuperzine
  3. Huperzine A for vascular dementia.
    Hao Z; Liu M; Liu Z; Lv D · The Cochrane database of systematic reviews · 2009
    Systematic review14 participants1 studies pooledCognitive Support forHuperzine
  4. Pharmacotherapy for Vascular Cognitive Impairment.
    Farooq MU; Min J; Goshgarian C; Gorelick PB · CNS drugs · 2018
    Narrative reviewBrain Health forHuperzine
  5. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledBrain Health Cognitive Support forHuperzine
  6. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledCognitive Support forHuperzine
  7. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsCognitive Support Brain Health forHuperzine
  8. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsBrain Health forHuperzine
  9. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsBrain Health Cognitive Support forHuperzine
  10. [Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: a systematic review and Meta-analysis].
    Huang P; Li B; Guo YH; Feng S; Hu J; Liu QQ · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2019
    Meta-analysis9 studies pooledBrain Health forHuperzine
  11. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis.
    Wang BS; Wang H; Wei ZH; Song YY; Zhang L; Chen HZ · Journal of neural transmission (Vienna, Austria : 1996) · 2009
    Meta-analysis4 studies pooledCognitive Support forHuperzine
  12. Huperzine A for Alzheimer's disease.
    Li J; Wu HM; Zhou RL; Liu GJ; Dong BR · The Cochrane database of systematic reviews · 2008
    Meta-analysis454 participants6 studies pooledCognitive Support forHuperzine
  13. Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study: implications for understanding the placebo effect.
    Zafonte RD; Fregni F; Bergin MJG; Goldstein R; Boudreau N; Monge I; Luz M; Frazier J; Giacino JT · Brain injury · 2021
    Randomized trialBrain Health forHuperzine
  14. The effects of Huperzine A on dementia and mild cognitive impairment: An overview of systematic reviews.
    Ghassab-Abdollahi N; Mobasseri K; Dehghani Ahmadabad A; Nadrian H; Mirghafourvand M · Phytotherapy research : PTR · 2021
    Systematic review6 studies pooledBrain Health forHuperzine
  15. The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis.
    Perng CH; Chang YC; Tzang RF · Psychopharmacology · 2019
    Meta-analysis44,854 participants235 studies pooledCognitive Support forHuperzine
  16. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsBrain Health forHuperzine
  17. The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis.
    Cui CC; Sun Y; Wang XY; Zhang Y; Xing Y · Medicine · 2019
    Meta-analysis33 studies pooledCognitive Support forHuperzine
  18. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsCognitive Support forHuperzine